Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
+0.11
(+0.13%)
USD |
NASDAQ |
Aug 31, 16:00
84.97
+0.02
(+0.02%)
After-Hours: 20:00
Crinetics Pharmaceuticals Total Long Term Debt (Quarterly) : 40.61M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.61M |
| March 31, 2026 | 41.32M |
| December 31, 2025 | 42.05M |
| September 30, 2025 | 42.70M |
| June 30, 2025 | 43.33M |
| March 31, 2025 | 43.94M |
| December 31, 2024 | 44.57M |
| September 30, 2024 | 45.13M |
| June 30, 2024 | 45.87M |
| March 31, 2024 | 46.71M |
| December 31, 2023 | 47.56M |
| September 30, 2023 | 48.18M |
| June 30, 2023 | 1.456M |
| March 31, 2023 | 1.743M |
| December 31, 2022 | 2.024M |
| September 30, 2022 | 2.30M |
| June 30, 2022 | 2.565M |
| March 31, 2022 | 2.822M |
| December 31, 2021 | 3.074M |
| Date | Value |
|---|---|
| September 30, 2021 | 3.322M |
| June 30, 2021 | 3.558M |
| March 31, 2021 | 3.788M |
| December 31, 2020 | 4.014M |
| September 30, 2020 | 4.234M |
| June 30, 2020 | 4.444M |
| March 31, 2020 | 4.648M |
| December 31, 2019 | 4.849M |
| September 30, 2019 | 5.044M |
| June 30, 2019 | 5.226M |
| March 31, 2019 | 5.401M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.978B |
| Johnson & Johnson | 37.34B |
| Eli Lilly & Co. | 49.62B |
| Bristol Myers Squibb Co. | 44.59B |
| Corcept Therapeutics, Inc. | 7.504M |